Abstract:The discovery of small molecular inhibitors targeting essential and conserved bacterial drug targets such as FtsZ protein is a promising approach to fight against multi-drug resistant bacteria. In the present study, two new series of FtsZ inhibitors based on a 1-methylquinolinium scaffold were synthesized. The inhibitors possess a variety of substituent groups including the cyclic or linear amine skeleton at the 2- and 4-position of the quinolinium ring for structure-activity relationship study. In general, the inhibitors bearing a cyclic amine substituent at the 4-position of the quinolinium ring showed better antibacterial activity (MIC down to 0.25 μg/mL) than that at the 2-position, especially against Gram-positive bacteria. Among the twenty FtsZ inhibitors examined in various assays, A3 was identified to exhibit excellent antibacterial activity against S. aureus (MIC = 0.5–1 μg/mL), S. epidermidis (MIC = 0.25 μg/mL) and E. faecium (MIC = 1–8 μg/mL). More importantly, A3 showed low hemolytic toxicity (IC5 = 64 μg/mL) and was found not readily to induce drug resistance. A3 at 2–8 μg/mL promoted the polymerization of FtsZ and interrupted the bacterial division. Furthermore, the ligand-FtsZ interaction study conducted with circular dichroism and molecular docking revealed that A3 induced secondary structure changes of FtsZ protein upon binding to the interdomain cleft of the protein. A3 is thus a potent inhibitor of FtsZ and shows potential to be used as a new antibacterial agent against drug-resistant bacteria.

The Synthesis and Antibacterial Activity of Novel 3-O-arylalkylbenzamide Derivatives As FtsZ Inhibitors

Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ.

Synthesis and Biological Evaluation of Novel FtsZ‐targeted 3‐arylalkoxy‐2,6‐difluorobenzamides as Potential Antimicrobial Agents

Design, Synthesis and Biological Activity Evaluation of Novel 2,6-Difluorobenzamide Derivatives Through FtsZ Inhibition

Synthesis and Antibacterial Activity of Novel 4‐bromo‐1h‐indazole Derivatives As FtsZ Inhibitors

Synthesis and in vitro Antibacterial Activities of Some Bis-Oxazolidinones

Synthesis and antibacterial activity of novel icariin derivatives.

Design, Synthesis of Novel 4,5-Dihydroisoxazole-containing Benzamide Derivatives As Highly Potent FtsZ Inhibitors Capable of Killing a Variety of MDR Staphylococcus Aureus.

Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents

Design, Synthesis and Antibacterial Activity of Cinnamaldehyde Derivatives As Inhibitors of the Bacterial Cell Division Protein FtsZ

Novel Benzothiazole‒urea Hybrids: Design, Synthesis and Biological Activity As Potent Anti-Bacterial Agents Against MRSA.

Design, Synthesis and Structure-Based Optimization of Novel Isoxazole-Containing Benzamide Derivatives As FtsZ Modulators.

Novel Benzyl Phenyl Sulfide Derivatives As Antibacterial Agents Against Methicillin-Resistant Staphylococcus Aureus

3-Phenyl substituted 6,7-dimethoxyisoquinoline derivatives as FtsZ-targeting antibacterial agents

Antimicrobial Action and Reversal of Resistance in MRSA by Difluorobenzamide Derivatives Targeted at FtsZ.

Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors.

Design, Synthesis and Antimicrobial Evaluation of Novel Benzoxazole Derivatives.

Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study

Synthesis and biological evaluations of novel benzimidazoles as potential antibacterial agents.

Design, Synthesis and Biological Evaluation of 3-(4-halophenyl)-3-oxopropanal and Their Derivatives As Novel Antibacterial Agents

Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.